Multifocal motor neuropathy with conduction block associated with metastatic lymphoma of the nervous system

J Neurooncol. 2006 May;78(1):81-4. doi: 10.1007/s11060-005-9060-6.

Abstract

Peripheral neuropathies occur in 5% of patients with Non-Hodgkin Lymphoma and represent the effects of therapy, direct compression or nerve infiltration by tumor, or paraneoplastic effects. Multifocal motor neuropathy with conduction block (MMNCB) is a rare demyelinating disorder of unknown etiology characterized by progressive, distal, asymmetric weakness mostly of the upper limbs with minimal or no sensory loss. We report a patient, who developed MMNCB at the time of isolated CNS relapse from a diffuse large B-cell lymphoma. Marked neurological improvement was achieved using intravenous immunoglobulin treatment. To our knowledge, MMNCB has thus far not been described as part of the spectrum of lymphoma-related peripheral neuropathies.

Publication types

  • Case Reports
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Antineoplastic Combined Chemotherapy Protocols / therapeutic use*
  • Cyclophosphamide / administration & dosage
  • Demyelinating Diseases / complications
  • Demyelinating Diseases / physiopathology
  • Female
  • Head and Neck Neoplasms / pathology
  • Humans
  • Immunoglobulins, Intravenous / therapeutic use
  • Immunologic Factors / therapeutic use
  • Lymphoma, B-Cell / complications*
  • Lymphoma, B-Cell / drug therapy
  • Lymphoma, Large B-Cell, Diffuse / complications*
  • Lymphoma, Large B-Cell, Diffuse / drug therapy
  • Methotrexate / administration & dosage
  • Middle Aged
  • Motor Neuron Disease / complications*
  • Motor Neuron Disease / physiopathology
  • Neoplasm Recurrence, Local / pathology
  • Nervous System Neoplasms / complications*
  • Nervous System Neoplasms / drug therapy
  • Neural Conduction
  • Peripheral Nervous System Diseases / complications
  • Peripheral Nervous System Diseases / physiopathology
  • Scalp / pathology
  • Skin Neoplasms / pathology
  • Thiotepa / administration & dosage
  • Vincristine / administration & dosage

Substances

  • Immunoglobulins, Intravenous
  • Immunologic Factors
  • Vincristine
  • Cyclophosphamide
  • Thiotepa
  • Methotrexate